Psilocybin Training I

Date of training: 2023


Experiential Psilocybin Training Program

This program is intended for therapists and medical professionals who have attended one of the theory-based training courses in psychedelic-assisted therapy and seeking first-hand, legal experience with psilocybin.

Participants will engage in a guided journey under the influence of psilocybin aimed at learning how to integrate the use of psilocybin in their clinical practices as well as gaining insight into the inner workings of the mind and facilitating deep personal insight and growth.

The program is designed with a focus on creating a safe, supportive and nurturing environment for participants to explore their thoughts, feelings and beliefs. Participants will also engage in a range of preparatory activities and integration sessions to maximise the benefits of the experience and support their continued growth and development.


1. Introduction to Psilocybin-Assisted Therapy
– History and context of psilocybin use in therapy
– The legal and ethical framework for psilocybin-assisted therapy
– Current research in the field
– Safety considerations

2. Pharmacology and Neurobiology of Psilocybin
– Chemical properties of psilocybin
– Mechanisms of action in the brain
– Neuroplasticity and the potential for healing

3. Screening and Preparation of Patients
– Patient assessment and selection criteria
– Pre-treatment preparation and education
– Risks and contraindications
– Legal and ethical considerations

4. Psilocybin-Assisted Therapy Session Protocols
– Session set-up and preparation
– Role of the therapist and integration support
– Therapeutic methods and techniques
– Dosage and administration protocols
– Dealing with challenging experiences

5. Integration and Ongoing Care
– Integration support following treatment sessions
– Follow-up and monitoring of progress
– Long-term care and prevention of relapse
– Therapist self-care and management of countertransference

6. Experiential Learning and Practice
– Supervised practice sessions with psilocybin
– Supervised observation of psilocybin-assisted therapy sessions
– Role-playing exercises and simulated scenarios
– Case studies and group discussions

7. Ethics and Legal Issues in Psilocybin-Assisted Therapy
– Informed consent and patient rights
– Confidentiality and record-keeping
– Ethical dilemmas and challenges
– Collaboration with regulatory bodies and other healthcare providers

8. Conclusion and Future Directions
– Reflection and integration of learning
– Current challenges and opportunities in the field
– Future directions and emerging research

Privacy Policy

In the following, we inform you about which data we process when you visit this website as well as when you make entries and enquiries about this website. In addition, we provide you with information that is necessary to ensure fair and transparent processing of personal data.

Our online offer contains links to Internet pages of other providers, We have no influence on whether these providers comply with the statutory data protection provisions.

Data processing when visiting this website

Personal data is not collected or processed when accessing this Internet site. For the provision of the offer and for quantitative measurement of the accesses, only the following data are temporarily stored in a log file:
– anonymised IP address
– name of the file accessed and amount of data transferred
– date and time of the call
– request details and destination address (protocol version, HTTP method, referrer, user agent string)
– message whether the call was successful

So called temporary cookies are used when calling up individual pages. These session cookies do not contain any personal data and expire at the end of the session. Session cookies and only used to enable and ensure the necessary technical functions or to make the website user-friendly and optimally adapt it to the user’s needs. No cookies are used to identify users and to evaluate user behaviour (no so-called web tracking).

Submissions and inquiries

Thw website only processes such data in connection with submissions and inquiries to this offer that are necessary to communicate with you and to properly document administrative actions. This includes in particular personal information (e.g. surname, first name, address, e-mail address, etc.) that we have received directly from you yourself, as well as information about the contact channel you have chosen (telephone, e-mail, contact form). The processing of the data is necessary for the performance of our tasks (cf. Article 6(1)(e) GDPR).

We will only pass on the data we receive from you to third parties if you have expressly consented to this or if we are obliged to do so by law or on the basis of a court decision.

The submission and inquiries in electronic form – as well as in paper form – is carried out in accordance with the time limits applicable to the storage of written material in the Registration Directive, which supplements the Joint Rules of Procedure of the Federal Ministries. As a rule, the retention periods for this are 10 years.

For information on the rights of persons affected by the processing of personal data and on how to lodge a complaint, please refer to the data protection information on the GDPR website of the European Union, which you can access via these links: &


At Soma Institute we are expertly trained, have years of experience with non-ordinary states of consciousness and we help with preparation, education and integration of psychedelic experiences. We offer a safe, non-judgmental, and confidential space to process non-ordinary states and their potential for growth and transformation. 

We do not provide, condone, or support the use of illegal substances. There are significant legal and medical risks associated with the use of psychedelics. These risks are amplified for people who are experiencing mental health difficulties. 

At Soma Institute we facilitate legal psychedelic retreats and/or provide help to those who have had a psychedelic journey and need support with unpacking and making sense of the psychic material that was brought up during the experience. We do not recommend or endorse any specific procedures, opinions, or other information that may be mentioned on this web site. We encourage you to do your own research and due-diligence.

The information available on this website is not intended as medical advice or a substitute for obtaining medical advice. Soma Institute assumes no responsibility for the suitability of psychedelic medicine for any purpose. You are encouraged to review all information regarding any medical condition or treatment with your physician. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on, or accessed through, this website.